SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-042874
Filing Date
2024-10-04
Accepted
2024-10-04 16:02:03
Documents
13
Period of Report
2024-10-02
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K ef20036713_8k.htm   iXBRL 8-K 26787
  Complete submission text file 0001140361-24-042874.txt   164533

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atai-20241002.xsd EX-101.SCH 3856
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE atai-20241002_lab.xml EX-101.LAB 22690
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atai-20241002_pre.xml EX-101.PRE 16546
15 EXTRACTED XBRL INSTANCE DOCUMENT ef20036713_8k_htm.xml XML 4213
Mailing Address 524 BROADWAY NEW YORK NY 10013
Business Address WALLSTRASSE 16 BERLIN 2M 10179 (617)-699-5876
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40493 | Film No.: 241354873
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)